Concepedia

Interchangeability Rules

Interchangeability Rules is a regulatory framework within step therapy policies that specifies the criteria and conditions under which one pharmaceutical agent may be substituted for another in a treatment sequence, based on demonstrated therapeutic equivalence and safety.

15

Publications

561

Citations

45

Authors

34

Institutions

Publications per year

2017–2026

5

Parents

Publications

15

Patent Scope and Innovation in the Software Industry

Julie E. Cohen, Mark A. Lemley · California Law Review · 2001 · 142 citations

, , +15

Patent Scope and Innovation in the Software Industry

Julie E. Cohen · California Law Review · 2001 · 105 citations · Full text

, , +15

A ‘Global Reference’ Comparator for Biosimilar Development

Chris Webster, Gillian R. Woollett · BioDrugs · 2017 · 43 citations · Full text

, , +16

Patent Scope and Innovation in the Software Industry

Mark A. Lemley, Julie E. Cohen · SSRN Electronic Journal · 2000 · 43 citations · Full text

, , +15

Using linear regression to assess dose-dependent bias on a Bland-Altman plot

Kwok M. Ho · Journal of Emergency and Critical Care Medicine · 2018 · 34 citations · Full text

, , +6

1–5 of 15

Authors

45

  1. JE
    Julie E. Cohen

    Georgetown University, United States

    3 publications · 290 citations

    3

    h-index

  2. VP
    Vinod P. Shah

    Center for Drug Evaluation and Research, United States

    3 publications · 65 citations

    3

    h-index

  3. HB
    Henning Blume

    SocraTec R&D (Germany), Germany

    2 publications · 43 citations

    2

    h-index

  4. YC
    Yu Chung Tsang

    Apotex (Canada), Canada

    2 publications · 43 citations

    2

    h-index

  5. RV
    Raja Velagapudi

    United States Food and Drug Administration, United States

    2 publications · 43 citations

    2

    h-index

1–5 of 45

Institutions

34

  1. Apotex (Canada)

    Toronto, Canada

    2 h-index

    2 publications

    43 citations

  2. United States Food and Drug Administration

    Silver Spring, United States

    2 h-index

    6 publications

    129 citations

  3. Georgetown University

    Washington, United States

    2 h-index

    2 publications

    185 citations

  4. Teva Pharmaceuticals (United States)

    North Wales, United States

    2 h-index

    2 publications

    43 citations

  5. International Pharmaceutical Federation

    The Hague, Netherlands

    2 h-index

    2 publications

    43 citations

  6. SocraTec R&D (Germany)

    Erfurt, Germany

    2 h-index

    2 publications

    43 citations

  7. Merck & Co., Inc., Rahway, NJ, USA (United States)

    Rahway, United States

    2 h-index

    2 publications

    43 citations

  8. University of Lisbon

    Lisbon, Portugal

    2 h-index

    2 publications

    43 citations

1–8 of 34

Venues

  1. California Law Review

    2 publications · 247 citations

    2

    h-index

  2. Journal of Emergency and Critical Care Medicine

    JECCM · 1 publications · 34 citations

    1

    h-index

  3. Operations Research Letters

    1 publications · 27 citations

    1

    h-index

  4. Current Medical Research and Opinion

    CMRO · 1 publications · 12 citations

    1

    h-index

  5. Energy Conversion and Management

    1 publications · 14 citations

    1

    h-index

1–5